21st April 2021
- 0 comments
A team of top scientists from the University of Bristol have formed a new biotech company that is developing ground-breaking and newly patented potential treatments for Coronavirus.
Bristol-based Halo Therapeutics is backed by Charles Grimsdale (former Eden Ventures), Keith MacDonald and Mark Farmer (of Eden Ventures) and a group of Angels from the Bristol area. It was founded by the team of leading scientists who made a recent breakthrough discovery, which was published in Science Magazine. They found that exposing the SARS-CoV-2 (Coronavirus) virus to a free fatty acid called linoleic acid locks the virus’s spike protein into a closed, non-infective form stopping it in its tracks.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.